The treatment for various skin related problems is possible with the help of dermal filler products. Removal of wrinkles, scars, skin smoothening and other procedures can be done through dermal filler procedure. Though fearing the side effects, the growth in this market may have been slow; however, owing to the better availability of facilities and advancements made in technology and increase in ageing of the population, the market has been seeing a boost in its growth in recent years.

Dermal fillers are soft, gel-like substances that are injected under the skin. They can address a number of common concerns including smoothing of deep under-eye circles, lifting of cheekbones, volumization of the lips, smoothing of lip lines and nasolabilal folds (the creases that run from the side of the nose to the corners of the mouth), and rejuvenation of the hands.

Dermal fillers can be composed of a variety of substances, some naturally occurring and some synthetic. One of the most common compounds used in dermal fillers is hyaluronic acid (HA). HA is a naturally occurring substance found in human skin, and it plays a major role in keeping skin hydrated and volumized. HA fillers, depending on their specific chemical makeup, can last from six months to much longer before being gradually absorbed by the body.

Market Scope & Structural Analysis:

COVID-19 scenario analysis: 

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID-19 is expected to have a significant impact on the dermal filler market.

Top Impacting Factors:

• The demand for dermal fillers in the general population is one of the key factors driving the growth of the global dermal fillers market. There is increase in R&D initiatives in the dermal fillers industry, also there are recent regulatory approvals given. So, this is positively contributing to the growth of the market.
• The high proportion of older population and increasing pattern of early ageing due to the environmental factors such as pollution, are responsible for the growth in the market.
• Dermal fillers are being commonly adopted for lip augmentation among women for achieving plumper and fuller lips. In addition, fillers impart natural look to the lips at affordable cost and thus, are expected to be rapidly adopted in the market in future.

Growth factors:

• The dermal filler market is emerging owing to factors such as the less painful method of treating various problems relating to facial skin, lower occurrences of ailments that occur post-surgery, low level of pain, less scarring and requirement of smaller cuts. The dermal filler market is not only limited to the facial skin procedures but it also includes the treatment, which transforms body parts aesthetically. The increase in the ageing population has resulted in hike in demand for the anti-aging treatment. 
• This treatment is also useful   for rejuvenation of the skin and restoration of the lost collagen from the body. These factors have boosted the market growth. Moreover, high costs associated with the dermal filler procedures and also the side effects like redness, bruising and granulation of skin may hamper the market growth.

New product launches:

• In September 2019, Allergan plc. announced about receiving approval from the U.S. FDA for Juvéderm VOLUMA XC with TSK STERiGLIDE cannula for augmentation of cheeks in people aged above 21 years. The HA dermal filler is intended to correct age-related volume insufficiency in mid-face. The approval will expand the demand for the Juvederm family of fillers.

Key Segments Covered:

Key benefits of the report:

• This study presents the analytical depiction of the global dermal filler industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the dermal filler market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the dermal filler market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the dermal filler market.
• The report provides a detailed dermal filler market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Dermal Filler Market research report:

• Who are the leading market players active in the dermal filler market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the dermal filler market?
• What are the projections for the future that would help in taking further strategic steps?